Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

133
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
133
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

4.5K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.5K
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

447
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
447
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

What are the correlates of laboratory productivity in clinical laboratories in the Asia Pacific region?

Clinical biochemistry·2026
Same author

An improved approach to modelling patient reclassification: HbA<sub>1c</sub> as an example.

Clinical chemistry and laboratory medicine·2026
Same author

The value of external quality assurance programs in identifying shifts in high-sensitivity troponin assays: a case for careful selection of low-level target concentrations.

Pathology·2026
Same author

An analysis of 10 years of synovial fluid crystal external quality assurance data.

Pathology·2026
Same author

Nationwide Survey on Knowledge, Attitudes, and Practices regarding Reference Interval Utilization in Clinical Laboratories in Nepal.

EJIFCC·2026
Same author

An optimized method for setting Internal Quality Control targets (mean and limits) for multi-instrument Internal Quality Control strategies in hematology?

EJIFCC·2026
Same journal

Evaluation of hemoglobin interference thresholds for chemical urinalysis panels.

Clinical biochemistry·2026
Same journal

Integrated genomic and biochemical diagnosis of a novel homozygous start-loss variant in AKR1D1 associated with neonatal cholestasis.

Clinical biochemistry·2026
Same journal

Agreement between POC glucose meters and blood gas analyzers varies across ICU patient populations.

Clinical biochemistry·2026
Same journal

From variability to value: Advancing vancomycin therapeutic drug monitoring toward decision-grade practice through commutability-informed external quality assessment and uncertainty-aware reporting.

Clinical biochemistry·2026
Same journal

Response to the letter to the editor: From variability to value: Advancing vancomycin therapeutic drug monitoring toward decision-grade practice through commutability-informed external quality assessment and uncertainty-aware reporting.

Clinical biochemistry·2026
See all related articles

Related Experiment Video

Updated: Jul 13, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.2K

Methods for determining clinical utility.

Francis Bowling1, Tony Badrick2

  • 1Walter and Eliza Hall Institute, University of Melbourne, Australia.

Clinical Biochemistry
|October 16, 2023
PubMed
Summary
This summary is machine-generated.

Determining the clinical utility of diagnostic tests is crucial for patient care. This paper introduces methods to assess diagnostic test impact on patient outcomes and healthcare, even without extensive clinical trials.

Keywords:
Clinical utilityDiagnostic testPatient harmStandards of evidence

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.3K

Related Experiment Videos

Last Updated: Jul 13, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.2K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.3K

Area of Science:

  • Clinical diagnostics
  • Health services research
  • Medical decision-making

Background:

  • Clinical utility assessment evaluates a diagnostic test's impact on patient outcomes, clinical decisions, and resource use.
  • Requires patient medical history and outcomes data, often obtained through prospective studies or clinical trials.
  • Many established diagnostic tests lack determined clinical utility due to challenges in conducting trials and long-term patient monitoring.

Purpose of the Study:

  • To present methods for assessing the clinical utility of diagnostic tests.
  • To address the challenges faced by clinical laboratories in determining diagnostic test utility.
  • To provide practical approaches for evaluating the real-world impact of diagnostic tests.

Main Methods:

  • Discusses the use of patient outcomes data, including benefits and harms, to determine clinical utility.
  • Highlights the value of clinical trials as the highest evidence level for utility determination.
  • Proposes alternative or supplementary methods for utility assessment when full clinical trials are not feasible.

Main Results:

  • Clinical utility assessment is complex and often not performed for established tests.
  • Prospective studies and clinical trials are resource-intensive and may involve long-term patient follow-up.
  • The paper outlines methodologies to overcome these challenges in utility assessment.

Conclusions:

  • Effective methods are needed to assess the clinical utility of diagnostic tests.
  • Addressing challenges in data collection and study design is essential for accurate utility determination.
  • Implementing these methods can improve the understanding and application of diagnostic tests in healthcare.